pe
pep-05119 v1 CC-BY-SA-4.0

PBAN metabolic peptide

Targets the same receptor as diabetes and weight-loss drugs like Ozempic; studied as a possible metabolic treatment, not an approved medicine.

statuscomputed targetGLP-1R length33 aa refs1
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.825
pTM0.808
avg pLDDT70.8
ranking score0.731
STRUCTURE · PEP-05119 × GLP-1R
ranking0.731
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence33 aa
15101520253033
LADDMPATMAD QEVYRPEPEQI DSRNKYFSPRL
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.8252310156822205 boltz-2
ranking score 0.731449544429779 boltz-2
3-letter notation
Leu-Ala-Asp-Asp-Met-Pro-Ala-Thr-Met-Ala-Asp-Gln-Glu-Val-Tyr-Arg-Pro-Glu-Pro-Glu-Gln-Ile-Asp-Ser-Arg-Asn-Lys-Tyr-Phe-Ser-Pro-Arg-Leu
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategycolabfold_nvidia
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-26
citationbibtex
peptidemodel (2026). PBAN metabolic peptide (pep-05119, v1). PeptideModel. https://peptidemodel.com/card/pep-05119
@peptide{pep05119,
  sequence = {LADDMPATMADQEVYRPEPEQIDSRNKYFSPRL},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use